23andMe Holding (ME) Metrics: History & Chart

23andMe Holding Co. (ME)ME23andMe Holding Co.

About 23andMe Holding Co.

23andMe Holding Co. is a prominent direct-to-consumer genetic testing firm, structured around two primary business units: Consumer & Research Services and Therapeutics. Through its Consumer & Research Services division, the company provides individuals with a comprehensive suite of genetic reports, derived from a simple saliva sample collected via their proprietary kit. These reports offer insights into customers' genetic ancestral origins, predispositions to certain personal health risks, the likelihood of being a carrier for rare conditions that could be passed to offspring, and how their genetic makeup might influence responses to various medications. The Therapeutics segment is dedicated to pharmaceutical research and development, focusing on the discovery and advancement of novel treatments aimed at improving patient well-being across diverse medical fields, including oncology, respiratory, and cardiovascular diseases. This segment also engages in the out-licensing of intellectual property associated with identified drug targets that are progressing through clinical development. 23andMe maintains a strategic partnership with GlaxoSmithKline Intellectual Property (No.3) Limited, leveraging genetic insights to validate, develop, and ultimately commercialize new pharmaceutical products. Established in 2006, the company's corporate headquarters are situated in South San Francisco, California.

South San Francisco, CA

560 employees

www.23andme.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Joseph Selsavage

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	0.00%
30D Total Return	0.00%
YTD Total Return	0.00%
1Y Total Return	-67.05%
3Y Total Return	-98.66%
5Y Total Return	-99.71%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	0.00%
2025	-81.34%
2024	-82.21%
2023	-57.71%
2022	-67.57%
2021	-41.73%
2020

CAGR TTM	-67.07%
CAGR 3Y	-76.27%
CAGR 5Y	-68.93%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

ME Valuation Metrics

ME Stock Price Metrics

ME Dividend Metrics

ME Growth Rate Metrics

ME Discounted Cash Flow Metrics

ME Returns By Period

ME Yearly Returns

ME Average Annual Returns By Period (CAGR)

ME Revenue Metrics

ME PE Ratio Metrics

ME PS Ratio Metrics

ME PB Ratio Metrics

ME Price to Free Cash Flow Ratio Metrics

ME Debt to Equity Ratio Metrics

ME PEG Ratio Metrics

ME FCF Yield

ME Earnings Yield

ME EV/EBIT Ratio Metrics

ME EV/EBITDA Ratio Metrics

ME EV/Assets Ratio Metrics

ME EV/Sales Ratio Metrics

ME Current Ratio Metrics

ME Quick Ratio Metrics

ME ROIC Metrics

ME Return on Assets Metrics

ME Return on Equity Metrics

ME Net Profit Margin Metrics

ME Gross Profit Margin Metrics

ME Tax Rate Metrics

PS Ratio	0.10
PS Ratio Avg TTM	0.33
PS Ratio Avg 3Y	1.16
Current VS TTM Avg	-69.55%
Current VS 3Y Avg	-91.36%
Current VS 5Y Avg	-96.36%

PB Ratio	0.51
PB Ratio Avg TTM	0.50
PB Ratio Avg 3Y	0.88
Current VS TTM Avg	+2.66%
Current VS 3Y Avg	-41.87%
Current VS 5Y Avg	-54.02%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.83
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.26
Current VS TTM Avg	+115473.81%
Current VS 3Y Avg	+216.53%
Current VS 5Y Avg	+728.34%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	(924.20%)
FCF Yield Avg TTM	(496.25%)
FCF Yield Avg 3Y	(255.12%)
Current VS TTM Avg	+86.24%
Current VS 3Y Avg	+262.27%
Current VS 5Y Avg	+438.92%

Earnings Yield	(1471.24%)
Earnings Yield Avg TTM	(866.48%)
Earnings Yield Avg 3Y	(444.06%)
Current VS TTM Avg	+69.80%
Current VS 3Y Avg	+231.32%
Current VS 5Y Avg	+393.99%

Ev/Ebit Ratio	(0.20)
Ev/Ebit Ratio Avg TTM	(0.28)
Ev/Ebit Ratio Avg 3Y	(1.89)
Current VS TTM Avg	-27.27%
Current VS 3Y Avg	-89.39%
Current VS 5Y Avg	-97.44%

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.03
Ev/Assets Ratio Avg TTM	0.41
Ev/Assets Ratio Avg 3Y	0.25
Current VS TTM Avg	-92.64%
Current VS 3Y Avg	-88.04%
Current VS 5Y Avg	-93.99%

Ev/Sales Ratio	0.02
Ev/Sales Ratio Avg TTM	0.35
Ev/Sales Ratio Avg 3Y	0.64
Current VS TTM Avg	-94.36%
Current VS 3Y Avg	-96.86%
Current VS 5Y Avg	-98.93%

Current Ratio	0.81
Current Ratio Avg TTM	1.08
Current Ratio Avg 3Y	2.19
Current VS TTM Avg	-25.44%
Current VS 3Y Avg	-63.08%
Current VS 5Y Avg	-68.63%

Quick Ratio	0.69
Quick Ratio Avg TTM	0.97
Quick Ratio Avg 3Y	2.08
Current VS TTM Avg	-28.96%
Current VS 3Y Avg	-67.02%
Current VS 5Y Avg	-72.31%

ROIC	(553.10%)
ROIC Avg 3Y	(182.55%)
ROIC Avg 5Y	(143.76%)
Current VS 3Y Avg	+202.99%
Current VS 5Y Avg	+284.73%
Current VS 10Y Avg	+330.38%

ROA	(175.67%)
ROA Avg TTM	(172.19%)
ROA Avg 3Y	(99.08%)
Current VS TTM Avg	+2.02%
Current VS 3Y Avg	+77.30%
Current VS 5Y Avg	+111.28%

ROE	1050.35%
ROE Avg TTM	348.35%
ROE Avg 3Y	157.32%
Current VS TTM Avg	+201.52%
Current VS 3Y Avg	+567.63%
Current VS 5Y Avg	+1619.44%

Net Profit Margin	(93.74%)
Net Profit Margin Avg TTM	(141.52%)
Net Profit Margin Avg 3Y	(132.99%)
Current VS TTM Avg	-33.76%
Current VS 3Y Avg	-29.51%
Current VS 5Y Avg	-14.80%

Gross Profit Margin	53.23%
Gross Pft Margin Avg TTM	51.94%
Gross Pft Margin Avg 3Y	46.13%
Current VS TTM Avg	+2.48%
Current VS 3Y Avg	+15.38%
Current VS 5Y Avg	+13.13%

Tax Rate	0.02%
Tax Rate Avg 3Y	0.62%
Tax Rate Avg 5Y	0.41%
Current VS 3Y Avg	-96.75%
Current VS 5Y Avg	-95.12%
Current VS 10Y Avg	-94.31%